Artal Group’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $11.9M | Sell |
|
|||||
|
2023
Q4 | $28.8M | Sell |
|
|||||
|
2023
Q3 | $49.4M | Sell |
|
|||||
|
2023
Q2 | $57.3M | Buy |
|
|||||
|
2023
Q1 | $39.1M | Sell |
|
|||||
|
2022
Q4 | $48.8M | Hold |
|
|||||
|
2022
Q3 | $41.8M | Hold |
|
|||||
|
2022
Q2 | $43M | Hold |
|
|||||
|
2022
Q1 | $37.9M | Sell |
|
|||||
|
2021
Q4 | $69.3M | Sell |
|
|||||
|
2021
Q3 | $64M | Buy |
|
|||||
|
2021
Q2 | $36.1M | Hold |
|
|||||
|
2021
Q1 | $37M | Buy |
|
|||||
|
2020
Q4 | $57.7M | Sell |
|
|||||
|
2020
Q3 | $42.4M | Sell |
|
|||||
|
2020
Q2 | $52.8M | Sell |
|
|||||
|
2020
Q1 | $46.2M | Buy |
|
|||||
|
2019
Q4 | $29.2M | Buy |
|
|||||
|
2019
Q3 | $20.1M | Hold |
|
|||||
|
2019
Q2 | $31.2M | Sell |
|
|||||
|
2019
Q1 | $35.4M | Sell |
|
|||||
|
2018
Q4 | $28.7M | Sell |
|
|||||
|
2018
Q3 | $48.4M | Buy |
|
|||||
|
2018
Q2 | $45.3M | Buy |
|
|||||
|
2018
Q1 | $37.6M | Buy |
|
|||||
|
2017
Q4 | $14.4M | Buy |
|
|||||
|
2017
Q3 | $10.6M | Sell |
|
|||||
|
2017
Q2 | $14.1M | Sell |
|
|||||
|
2017
Q1 | $13.5M | Buy |
|
|||||
|
2016
Q4 | $8.7M | Sell |
|
|||||
|
2016
Q3 | $14.1M | Buy |
|
|||||
|
2016
Q2 | $6.83M | Buy |
|